相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Different effects of SLCO1B1 polymorphism on the pharmacokinetics of atorvastatin and rosuvastatin
M. K. Pasanen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
SLCO1B1 (OATP1B1, an uptake transporter) and ABCG2 (BCRP, an efflux transporter) variant alleles and pharmacokinetics of pitavastatin in healthy volunteers
I. Ieiri et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Effect of drug transporter genotypes on pravastatin disposition in European- and African-American participants
Richard H. Ho et al.
PHARMACOGENETICS AND GENOMICS (2007)
Pharmacogenetics of SLCO1B1:: haplotypes, htSNPs and hepatic expression in three distinct Asian populations
Srinivasa Rao Jada et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2007)
Influence of drug transporter polymorphisms on pravastatin pharmacokinetics in humans
Kari T. Kivisto et al.
PHARMACEUTICAL RESEARCH (2007)
Genetic variations and frequencies of major Haplotypes in SLCO1B1 encoding the transporter OATP1B1 in Japanese subjects: SLCO1B1*17 is more prevalent than*15
Su-Ryang Kim et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide
Wei Zhang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Pharmacogenetics of SLCO1B1 gene and the impact of *1b and*15 haplotypes on irinotecan disposition in Asian cancer patients
Xiaoqiang Xiang et al.
PHARMACOGENETICS AND GENOMICS (2006)
Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes
Mia Hedman et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Effects of organic anion transporting polypeptide IBI haplotype on pharmacokinetics of pravastatin, valsartan, and temocapril
Kazuya Maeda et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Influence of the SLCO1B1*1b and *5 haplotypes on pravastatin's cholesterol lowering capabilities and basal sterol serum levels
T Gerloff et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2006)
Genetic polymorphisms in KCNQ1, HERG, KCNE1 and KCNE2 genes in the Chinese, Malay and Indian populations of Singapore
SH Koo et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Organic anion transporting polypeptide 1B1 activity classified by SLCO1B1 genotype influences atrasentan pharmacokinetics
DA Katz et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2006)
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment
E Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Effect of OATPIBI (SLCOIBI) variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers
JY Chung et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Functional characterization of SLCO1B1 (OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells
Y Kameyama et al.
PHARMACOGENETICS AND GENOMICS (2005)
Polymorphic organic anion transporting polypeptide 1B1 is a major determinant of repaglinide pharmacokinetics
M Niemi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)
M Niemi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Role of organic anion transporter OATP1B1 (OATP-C) in hepatic uptake of irinotecan and its active metabolite, 7-ethyl-10-hydroxycamptothecin: In vitro evidence and effect of single nucleotide polymorphisms
T Nozawa et al.
DRUG METABOLISM AND DISPOSITION (2005)
High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)
M Niemi et al.
PHARMACOGENETICS (2004)
Functional analysis of single nucleotide polymorphisms of hepatic organic anion transporter OATP1B1 (OATP-C)
M Iwai et al.
PHARMACOGENETICS (2004)
Evidence for inverse effects of OATP-C (SLC21A6) *5 and *1b haplotypes on pravastatin kinetics
J Mwinyi et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes:: Consequences for pravastatin pharmacokinetics
Y Nishizato et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
The superfamily of organic anion transporting polypeptides
B Hagenbuch et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2003)
Genetic polymorphisms of human organic anion transporters OATP-C (SLC21A6) and OATP-B (SLC21A9): A nllele frequencies in the Japanese population and functional analysis
T Nozawa et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Polymorphisms in OATP-C -: Identification of multiple allelic variants associated with altered transport activity among European- and African-Americans
RG Tirona et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Molecular identification and characterization of novel members of the human organic anion transporter (OATP) family
I Tamai et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
